key: cord-0965279-42aqwrld authors: Saso, Anja; Skirrow, Helen; Kampmann, Beate title: Prioritising immunisation across the life course date: 2021-12-09 journal: Lancet DOI: 10.1016/s0140-6736(21)02331-x sha: b7c78485fcdeb29d0010f235c1d640f384cc0417 doc_id: 965279 cord_uid: 42aqwrld nan In addition to shortfalls in childhood vaccination delivery, we are deeply concerned about the ongoing collateral effect of the COVID-19 pandemic on maternal services, particularly immunisation programmes. Vaccines recommended in pregnancy against pertussis, tetanus, or influenza, or all, are established tools to protect not only pregnant women, but also infants during the vulnerable postnatal period. 3 Although country-specific data are emerging that show that maternal vaccine uptake declined in 2020, 4 to date, no similar global estimates of COVID-19-related disruptions to these services have been published. The IMmunising PRegnant women and INfants neTwork (IMPRINT), a global, interdisciplinary collaboration of key stakeholders in maternal and infant vaccinology, captured the grassroots experiences of changes to vaccine delivery among our network members by an initial online survey in April, 2020. 5 We reported issues from 18 countries across five continents related to service access (eg, logistical barriers) and provision (eg, staff shortages), as well as user concerns over attending appointments. 5 1 year on, in May, 2021, we repeated this survey, and it is evident that routine maternal and infant vaccination programmes are yet to fully recover, despite the local or national measures, or both, implemented to mitigate disruption. Key barriers that were reported are parental anxiety about the spread of COVID-19 infection when attending routine vaccination appointments and uncertainty around access to these services. As restrictions are lifted and in the wake of a year of declining vaccine coverage, there is now an increasing risk not only of ongoing COVID-19 transmission, but also of other vaccine-preventable diseases affecting pregnant women and infants. Following on from the study by Causey and colleagues, 1 we therefore urgently call for specific data and the robust quantification of COVID-19-related disruptions to maternal immunisation coverage and the subsequent effect on maternal and infant health outcomes. Efficiency and safety of maternity services need to be prioritised, with clearer communication to women on potential risks as well as any specific safety measures implemented. 6 Pregnant women are also at risk of severe outcomes from COVID-19. 7 Promoting and delivering COVID-19 immunisation itself in pregnancy, already recommended in many countries, not only confers protection 8 but might be one effective strategy to mitigate the current interruptions to antenatal vaccination programmes. 3 All authors are members of IMPRINT, which is funded by UK Research and Innovation and the Global Challenges Research Fund. BK participates in data safety monitoring boards for COVID-19 vaccines and advisory boards for the use of vaccines in pregnancy. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study Maternal immunisation: collaborating with mother nature Pertussis vaccination programme for pregnant women update: vaccine coverage in England Impact of COVID-19 on immunization services for maternal and infant vaccines: results of a survey conducted by IMPRINT-the IMmunising PRegnant women and INfants neTwork Maternal vaccines during the Covid-19 pandemic: a qualitative interview study with UK pregnant women Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis Association between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women For IMPRINT see Anja Saso and colleagues rightly emphasise the importance of quantifying pandemic-related effects on maternal immunisation, with the IMmunising PRegnant women and INfants neTwork highlighting the multifaceted disruptions in 2020 and incomplete recovery to date among 18 countries. 1 Our study, which modelled the effects of COVID-19 on routine childhood immunisation in 2020, 2 focused on one part of the life course where vaccination can improve health and wellbeing. But the ambition Lakruwan Wanniarachchi/Getty Images